Protara Therapeutics (TARA) Preferred Dividend Payments (2013 - 2017)

Protara Therapeutics (TARA) has reported Preferred Dividend Payments for 3 consecutive years, with $6.7 million the latest figure, recorded in Q3 2017.

• In Q3 2017, Preferred Dividend Payments changed N/A year-over-year to $6.7 million; the TTM figure through Sep 2017 stood at $16.5 million (up 41.6% YoY), while the FY2014 annual figure was $6.4 million, up 203.82% from the prior year.
• Preferred Dividend Payments fell to $6.7 million in Q3 2017 per TARA's latest filing, from $12.0 million in the prior quarter.
• Across five years, Preferred Dividend Payments topped out at $12.0 million in Q4 2014 and bottomed at -$10.7 million in Q4 2013.
• Historically, Preferred Dividend Payments has averaged $1.5 million across 3 years, with a median of $1.5 million in 2013.
• On a YoY basis, Preferred Dividend Payments climbed as much as 212.54% in 2014 and fell as far as 247.86% in 2014.
• Protara Therapeutics' Preferred Dividend Payments stood at -$10.7 million in 2013, then surged by 212.54% to $12.0 million in 2014, then slumped by 43.96% to $6.7 million in 2017.
• Business Quant data shows TARA's Preferred Dividend Payments at $6.7 million in Q3 2017, $12.0 million in Q4 2014, and -$2.3 million in Q3 2014.